SPRY4 and lung cancer: SPRY4 functions as a tumor suppressor downstream of Wnt7A/Fzd9 signaling in lung cancer, whose overexpression inhibited cell growth with upregulating the tumor suppressor p53 and p21 expression, and also suppressed cell migration and invasion along with MMP-9 activity [16].